ADMA Biologics Inc (ADMA)

Last Closing Price: 7.76 (2026-06-03)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ADMA Biologics Inc (ADMA) had Net Income of $45.33M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$114.49M
Net Income
$45.33M
$33.74M
$80.75M
$56.22M
$58.27M
$-1.15M
$57.13M
$57.13M
$45.33M
$45.33M
$45.33M
$45.33M
$58.27M
$60.27M
236.07M
239.96M
$0.19
$0.19
Balance Sheet Financials
$511.17M
$65.01M
$154.01M
$665.18M
$73.54M
$199.95M
$201.32M
$274.86M
$390.32M
$386.17M
$390.32M
232.29M
Cash Flow Statement Financials
$58.25M
$2.40M
$-10.13M
$87.63M
$138.15M
$50.52M
$6.33M
--
--
Fundamental Metrics & Ratios
6.95
--
--
0.34
0.52
70.53%
50.90%
50.90%
--
49.90%
39.59%
$60.71M
--
--
--
0.17
0.15
0.84
106.80
11.61%
11.74%
6.81%
7.68%
$1.68
$0.25
$0.24